CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 4 Grant or award Director acquired 237 shares (grant or award)
- 4 Grant or award Director acquired 153 shares (grant or award)
- 4 Planned sale Chief Executive Officer sold 20,000 shares at an average $136.85 ($2,736,945)
- 4 Grant or award Director acquired 148 shares (grant or award)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Growth Officer sold 7,873 shares at $146.39 ($1,152,528)
- 4 Open-market sale Chief Financial Officer sold 23,619 shares at $146.39 ($3,457,585)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 4,100 shares at an average $93.34 ($382,679)
- 4 Planned sale Chief Executive Officer sold 61,452 shares at an average $97.74 ($6,006,378)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 5,000 shares at $85.02 ($425,098)
- 4 Planned sale Chief Financial Officer sold 7,900 shares at $85.01 ($671,579)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 1 of 14 · 267 filings